Bridging the implementation gap in hereditary cancer care for prostate cancer: a narrative review and Japanese environmental scan.
BACKGROUND Genomic testing has become increasingly important in prostate cancer because BRCA1/2 and other genomic alterations can inform treatment selection and may indicate an underlying hereditary cancer syndrome. However, treatment-directed testing does not necessarily lead to genetic counseling, germline genetic te...